Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Apr 15, 2012 (Vol. 32, No. 8)


  • Free software downloads and other tools
  • Some restricted (not free) content

Pay close attention to your acronyms—this is not the place to go for information on disease control. Rather, this website for the Cambridge Crystallographic Data Centre (CCDC) contains a great deal of useful information for all of you crystallographers out there. A nonprofit institution in Cambridge, England, the CCDC provides a number of free resources to the research community that are accessible from their website on the “free services” page. On this page, visitors will find nine free tools ranging from software downloads, to databases, to a set of 500 crystallographic structures for teaching purposes. As an example of what you’ll find here, Mercury is a software package that includes tools for structure visualization, while Relibase is a web-based database of protein-ligand complexes. Want more? Head over to this cleanly designed website and take advantage of the charitable resources from the CCDC.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »